unknown
Stage
About
Vaccibody ASA is a Norwegian biotechnology company developing vaccines and immunotherapies using a DNA-based, modular platform that targets antigens to antigen-presenting cells to elicit T-cell and antibody responses. The company focuses on personalised cancer vaccines and vaccines for infectious diseases, and works with partners on clinical development.
Explore Vaccibody ASA's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.